Autologous bone marrow-derived mesenchymal stem cell therapy

· Vinmec Research Institute of Stem Cell and Gene Technology

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Autologous bone marrow-derived mesenchymal stem cell therapy, covering 2017-08-10 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes [Phase 1, Phase 2]

See pricing